Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Search for purdue pharma in registrations and monthly communication reports

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (35)
Results: 1-35 | Export
  1. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: David Pidduck, President & CEO
    Registration: 23 of 23 (2020-03-23 to 2020-09-16)
    Posted: 2020-03-24
    Subject matter details: 2
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  2. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: David Pidduck, President & CEO
    Registration: 22 of 23 (2019-07-16 to 2020-03-23)
    Posted: 2019-07-16
    Subject matter details: 2
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  3. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: David Pidduck, President & CEO
    Registration: 21 of 23 (2017-09-25 to 2019-07-16)
    Posted: 2017-10-02
    Subject matter details: 3
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  4. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 20 of 23 (2017-06-15 to 2017-09-25)
    Posted: 2017-06-21
    Subject matter details: 3
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  5. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 19 of 23 (2017-01-03 to 2017-06-15)
    Posted: 2017-01-23
    Subject matter details: 3
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  6. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, McMillan Vantage Policy Group / McMillan Avantage Group D'affaires Publiques
    Registration: 4 of 4 (2016-12-09 to 2017-02-01)
    Posted: 2016-12-14
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  7. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, THE ROTHWELL GROUP INC.
    Registration: 3 of 4 (2016-08-16 to 2016-12-09)
    Posted: 2016-08-18
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  8. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 4 of 4 (2016-07-12 to 2018-04-02)
    Posted: 2016-07-21
    Subject matter details: 3
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  9. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 18 of 23 (2016-04-21 to 2017-01-03)
    Posted: 2016-04-22
    Subject matter details: 2
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  10. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, THE ROTHWELL GROUP INC.
    Registration: 2 of 4 (2016-04-08 to 2016-08-16)
    Posted: 2016-04-11
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  11. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 17 of 23 (2016-02-12 to 2016-04-21)
    Posted: 2016-02-18
    Subject matter details: 2
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  12. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, THE ROTHWELL GROUP INC.
    Registration: 1 of 4 (2016-01-25 to 2016-04-08)
    Posted: 2016-01-29
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  13. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 16 of 23 (2015-07-16 to 2016-02-12)
    Posted: 2015-07-20
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  14. PURDUE PHARMA
    Type: Consultant
    Lobbyist: Ann Marie Pullen, Global Public Affairs
    Registration: 2 of 2 (2015-04-30 to 2016-02-24)
    Posted: 2015-05-01
    Subject matter details: 3
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  15. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 3 of 4 (2015-04-30 to 2016-07-12)
    Posted: 2015-05-01
    Subject matter details: 3
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  16. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 15 of 23 (2015-02-02 to 2015-07-16)
    Posted: 2015-02-02
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 5
  17. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 14 of 23 (2014-11-24 to 2015-02-02)
    Posted: 2014-11-24
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  18. PURDUE PHARMA
    Type: Consultant
    Lobbyist: Ann Marie Pullen, Global Public Affairs
    Registration: 1 of 2 (2014-08-01 to 2015-04-30)
    Posted: 2014-08-06
    Subject matter details: 3
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  19. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 2 of 4 (2014-07-21 to 2015-04-30)
    Posted: 2014-08-01
    Subject matter details: 3
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  20. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 13 of 23 (2014-06-15 to 2014-11-24)
    Posted: 2014-06-18
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  21. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Craig Landau, President & CEO
    Registration: 12 of 23 (2013-09-01 to 2014-06-15)
    Posted: 2013-09-23
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 3
  22. Purdue Pharma Canada
    Type: Consultant
    Lobbyist: ROBERT EVERSHED, PROSPECTUS ASSOCIATES IN CORPORATE DEVELOPMENT INC
    Registration: 1 of 1 (2012-11-07 to 2015-12-10)
    Posted: 2012-11-15
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  23. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Cornelia Hentzsch, President
    Registration: 11 of 23 (2012-10-23 to 2013-09-01)
    Posted: 2012-10-23
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 3
  24. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Cornelia Hentzsch, President
    Registration: 10 of 23 (2012-05-07 to 2012-10-23)
    Posted: 2012-05-10
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 3
  25. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Cornelia Hentzsch, President
    Registration: 9 of 23 (2012-04-26 to 2012-05-07)
    Posted: 2012-05-07
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 3
  26. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Cornelia Hentzsch, President
    Registration: 8 of 23 (2010-04-28 to 2011-02-02)
    Posted: 2010-09-01
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 2
  27. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: Cornelia Hentzsch, President
    Registration: 7 of 23 (2009-01-01 to 2010-04-03)
    Posted: 2009-10-09
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 2
  28. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: John Stewart, Executive Vice President and GM
    Registration: 6 of 23 (2008-03-03 to 2009-01-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 7
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 2
  29. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: John Stewart, Executive Vice President and GM
    Registration: 5 of 23 (2007-08-01 to 2008-03-03)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 7
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 2
  30. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: John Stewart, Executive Vice President and GM
    Registration: 4 of 23 (2007-02-13 to 2007-08-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 4
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 2
  31. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: John Stewart, Executive Vice President and GM
    Registration: 3 of 23 (2006-08-23 to 2007-02-13)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 4
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 2
  32. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: John Stewart, Executive Vice President and GM
    Registration: 2 of 23 (2006-02-24 to 2006-08-23)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 4
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 2
  33. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: John Stewart, Executive Vice President and GM
    Registration: 1 of 23 (2005-08-17 to 2006-02-24)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 4
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 2
  34. PURDUE PHARMA
    Type: In-house Corporation
    Responsible officer: RANDY STEFFAN, DIRECTOR, CORPORATE AFFAIRS AND COMMUNICATIONS
    Registration: 1 of 1 (2005-04-14 to 2005-06-10)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
  35. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, HILL AND KNOWLTON CANADA
    Registration: 1 of 4 (2001-11-14 to 2004-08-13)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 5
    Government funding: No

Monthly communication reports (68)
Results: 1-50 | Export
  1. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2017-11-02
    Posted: 2017-12-15
    Designated public office holders:
    • Suzy McDonald, Assistant Deputy Minister, Opioid Response Team | Health Canada (HC)
    Subject matters:
    • Justice and Law Enforcement
    • Science and Technology
    • Health
    • Industry
  2. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-11-15
    Posted: 2016-12-15
    Designated public office holders:
    • Kevin Sorenson, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Intellectual Property
    • Industry
    • Health
    • Aboriginal Affairs
    • Justice and Law Enforcement
  3. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, THE ROTHWELL GROUP INC.
    Occurred: 2016-10-13
    Posted: 2016-11-02
    Designated public office holders:
    • Arthur Eggleton, Senator | Senate of Canada
    Subject matters:
    • Justice and Law Enforcement
    • Health
  4. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, THE ROTHWELL GROUP INC.
    Occurred: 2016-10-05
    Posted: 2016-11-02
    Designated public office holders:
    • Marci Surkes, Chief of Staff, Office of the Minister | Public Safety Canada (PS)
    • Ralph Goodale, Minister | Public Safety Canada (PS)
    • David Hurl, Director of Policy and Public Affairs, Office of the Minister | Public Safety Canada (PS)
    Subject matters:
    • Justice and Law Enforcement
  5. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-10-05
    Posted: 2016-11-15
    Designated public office holders:
    • Vernon White, Senator | Senate of Canada
    Subject matters:
    • Industry
    • Justice and Law Enforcement
    • National Security/Security
    • Health
    • Science and Technology
  6. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-10-05
    Posted: 2016-11-15
    Designated public office holders:
    • David Hurl, Director of Policy, Office of the Minister | Public Safety Canada (PS)
    • Marci Surkes, Chief of Staff, Office of the Minister | Public Safety Canada (PS)
    • Ralph Goodale, Minister | Public Safety Canada (PS)
    Subject matters:
    • Health
    • Justice and Law Enforcement
    • National Security/Security
    • Science and Technology
    • Industry
  7. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-10-04
    Posted: 2016-11-15
    Designated public office holders:
    • Kelvin Ogilvie, Senator | Senate of Canada
    Subject matters:
    • Health
    • Justice and Law Enforcement
    • Industry
    • Science and Technology
  8. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-09-22
    Posted: 2016-10-15
    Designated public office holders:
    • Kevin Sorenson, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Health
    • Justice and Law Enforcement
    • Science and Technology
    • Industry
  9. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-09-09
    Posted: 2016-10-15
    Designated public office holders:
    • Colin Carrie, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Health
    • Industry
    • Justice and Law Enforcement
  10. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-09-08
    Posted: 2016-10-15
    Designated public office holders:
    • Hilary Geller, Assistant Deputy Minister, Healthy Environments and Community Safety Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Justice and Law Enforcement
    • Health
    • Science and Technology
  11. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-09-07
    Posted: 2016-10-15
    Designated public office holders:
    • Jennifer O'Connell, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Justice and Law Enforcement
    • Health
    • Science and Technology
  12. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-08-30
    Posted: 2016-09-15
    Designated public office holders:
    • Peter Harder, Senator | Senate of Canada
    Subject matters:
    • Industry
    • Health
    • Science and Technology
    • Justice and Law Enforcement
  13. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-06-20
    Posted: 2016-07-15
    Designated public office holders:
    • Colin Carrie, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • International Trade
    • Health
    • Justice and Law Enforcement
  14. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-05-11
    Posted: 2016-06-15
    Designated public office holders:
    • Judy Sgro, Member of Parliament | House of Commons
    • Wayne Easter, Member of Parliament | House of Commons
    • Gordon Brown, Member of Parliament | House of Commons
    • Francesco Sorbara, Member of Parliament | House of Commons
    • David Tilson, Member of Parliament | House of Commons
    • Wilfred Moore, Senator | Senate of Canada
    • Brian Masse, Member of Parliament | House of Commons
    • David McGuinty, Member of Parliament | House of Commons
    • Michael MacDonald, Senator | Senate of Canada
    • Yvonne Jones, Member of Parliament | House of Commons
    • Phil McColeman, Member of Parliament | House of Commons
    • Brad Trost, Member of Parliament | House of Commons
    • Sherry Romanado, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Justice and Law Enforcement
    • Health
    • Industry
  15. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-05-04
    Posted: 2016-06-15
    Designated public office holders:
    • Hilary Geller, Assistant Deputy Minister, Healthy Environments and Consumer Safety | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
    • Justice and Law Enforcement
  16. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-05-04
    Posted: 2016-06-15
    Designated public office holders:
    • Wayne Easter, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Science and Technology
    • National Security/Security
    • Industry
    • Justice and Law Enforcement
  17. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-04-21
    Posted: 2016-05-16
    Designated public office holders:
    • Colin Carrie, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Intellectual Property
    • Justice and Law Enforcement
    • Industry
    • Science and Technology
  18. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-04-21
    Posted: 2016-05-16
    Designated public office holders:
    • Vernon White, Senator | Senate of Canada
    Subject matters:
    • Science and Technology
    • Intellectual Property
    • Justice and Law Enforcement
    • Industry
    • Health
  19. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, THE ROTHWELL GROUP INC.
    Occurred: 2016-04-15
    Posted: 2016-05-16
    Designated public office holders:
    • Tyler Meredith, Policy Advisor, Prime Ministers Office | Prime Minister's Office (PMO)
    Subject matters:
    • Justice and Law Enforcement
    • Intellectual Property
    • Health
  20. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-04-14
    Posted: 2016-05-16
    Designated public office holders:
    • Giovanni (John) Prato, Consul General of Canada in New York | Global Affairs Canada (GAC)
    Subject matters:
    • Industry
    • Justice and Law Enforcement
    • Intellectual Property
    • Health
    • Science and Technology
    • International Trade
  21. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-04-12
    Posted: 2016-05-16
    Designated public office holders:
    • Len Webber, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Science and Technology
    • Health
    • Industry
    • Justice and Law Enforcement
  22. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-04-07
    Posted: 2016-05-16
    Designated public office holders:
    • Rob Oliphant, Member of Parliament | House of Commons
    Subject matters:
    • National Security/Security
    • Health
    • Justice and Law Enforcement
    • Science and Technology
    • Industry
    • Intellectual Property
  23. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, THE ROTHWELL GROUP INC.
    Occurred: 2016-04-06
    Posted: 2016-04-08
    Designated public office holders:
    • Don Davies, MP | House of Commons
    Subject matters:
    • Health
  24. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-03-21
    Posted: 2016-04-15
    Designated public office holders:
    • Ron McKinnon, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
    • Intellectual Property
    • Science and Technology
  25. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-03-21
    Posted: 2016-04-15
    Designated public office holders:
    • Celina Caesar-Chavannes, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Industry
    • Aboriginal Affairs
    • Health
    • Intellectual Property
  26. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-03-17
    Posted: 2016-04-15
    Designated public office holders:
    • Greg Fergus, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Health
    • Industry
    • Intellectual Property
  27. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-03-11
    Posted: 2016-04-15
    Designated public office holders:
    • Steven MacKinnon, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Justice and Law Enforcement
    • Science and Technology
    • Health
  28. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-03-08
    Posted: 2016-04-15
    Designated public office holders:
    • Jennifer O'Connell, Member of Parliament | House of Commons
    Subject matters:
    • Justice and Law Enforcement
    • Science and Technology
    • International Trade
    • Industry
    • Health
  29. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-03-04
    Posted: 2016-04-15
    Designated public office holders:
    • Caroline Pitfield, Director of Policy, Office of the Minister | Health Canada (HC)
    • Kathryn Nowers, Policy Advisor, Office of the Minister | Health Canada (HC)
    Subject matters:
    • Intellectual Property
    • Health
    • Justice and Law Enforcement
    • Industry
    • Science and Technology
  30. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Occurred: 2016-03-04
    Posted: 2016-04-15
    Designated public office holders:
    • Kathryn Nowers, Policy Advisor, Office of the Minister | Health Canada (HC)
    • Caroline Pitfield, Director of Policy, Office of the Minister | Health Canada (HC)
    Subject matters:
    • Health
  31. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-02-23
    Posted: 2016-03-15
    Designated public office holders:
    • Pablo Rodriguez, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Intellectual Property
    • Industry
    • Science and Technology
  32. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-02-18
    Posted: 2016-03-15
    Designated public office holders:
    • Hilary Geller, Assistant Deputy Minister, Healthy Environments and Consumer Safety Branch | Health Canada (HC)
    Subject matters:
    • Science and Technology
    • Industry
    • Justice and Law Enforcement
    • Health
  33. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-02-10
    Posted: 2016-03-15
    Designated public office holders:
    • Stephanie Muccilli, Policy Advisor, Office of the Minister of Science | Innovation, Science and Economic Development Canada (ISED)
    • John Burnett, Director of Policy, Office of the Minister of Science | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Aboriginal Affairs
    • Justice and Law Enforcement
    • Health
    • Science and Technology
  34. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-02-08
    Posted: 2016-03-15
    Designated public office holders:
    • Andrew Leslie, Member of Parliament | House of Commons
    Subject matters:
    • Justice and Law Enforcement
    • Science and Technology
    • Health
    • Industry
  35. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-02-05
    Posted: 2016-03-15
    Designated public office holders:
    • Ben Lobb, Member of Parliament | House of Commons
    Subject matters:
    • Justice and Law Enforcement
    • Health
    • Science and Technology
    • Industry
  36. Purdue Pharma
    Type: Consultant
    Lobbyist: MARK RESNICK, THE ROTHWELL GROUP INC.
    Occurred: 2016-02-02
    Posted: 2016-03-15
    Designated public office holders:
    • Don Davies, MP | House of Commons
    Subject matters:
    • Justice and Law Enforcement
    • Health
    • Science and Technology
  37. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-02-02
    Posted: 2016-03-15
    Designated public office holders:
    • Dr. Kellie Leitch, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Health
    • Industry
    • Justice and Law Enforcement
  38. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-02-02
    Posted: 2016-03-15
    Designated public office holders:
    • Don Davies, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Justice and Law Enforcement
    • Industry
    • Science and Technology
  39. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2016-01-29
    Posted: 2016-02-03
    Designated public office holders:
    • Garry Keller, Chief of Staff, Office of the Leader of the Official Opposition | House of Commons
    Subject matters:
    • Industry
    • Science and Technology
    • Health
    • Justice and Law Enforcement
  40. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2015-12-02
    Posted: 2016-01-15
    Designated public office holders:
    • Hedy Fry, Memer of Parliament | House of Commons
    Subject matters:
    • Health
    • Justice and Law Enforcement
    • Science and Technology
    • Intellectual Property
  41. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2015-08-13
    Posted: 2015-09-15
    Designated public office holders:
    • James Maunder, Chief of Staff, Office of the Minister | Industry Canada
    Subject matters:
    • Industry
    • Health
    • Justice and Law Enforcement
    • Science and Technology
  42. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2015-07-10
    Posted: 2015-08-15
    Designated public office holders:
    • Sean Speer, Special Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Justice and Law Enforcement
    • Industry
    • Health
  43. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2015-04-30
    Posted: 2015-05-15
    Designated public office holders:
    • Ben Lobb, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Justice and Law Enforcement
    • Industry
  44. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2015-04-17
    Posted: 2015-05-15
    Designated public office holders:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Intellectual Property
    • Justice and Law Enforcement
    • Industry
  45. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2015-04-15
    Posted: 2015-05-15
    Designated public office holders:
    • Paul Halucha, Associate Assistant Deputy Minister | Industry Canada
    • John Knubley, Deputy Minister | Industry Canada
    Subject matters:
    • Intellectual Property
    • Health
    • Industry
    • International Trade
    • Science and Technology
  46. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2015-03-23
    Posted: 2015-04-15
    Designated public office holders:
    • John Weston, Member of Parliament | House of Commons
    Subject matters:
    • Justice and Law Enforcement
    • Industry
    • Health
  47. Purdue Pharma Canada
    Type: Consultant
    Lobbyist: ROBERT EVERSHED, PROSPECTUS ASSOCIATES IN CORPORATE DEVELOPMENT INC
    Occurred: 2014-09-11
    Posted: 2014-10-15
    Designated public office holders:
    • Ben Lobb, Member of Parliament - Huron - Bruce | House of Commons
    • Patrick Brown, Member of Parliament - Barrie | House of Commons
    • Peter Kent, Member of Parliament - Thornhill | House of Commons
    Subject matters:
    • Intellectual Property
    • Health
    • National Security/Security
    • Research and Development
  48. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Occurred: 2014-07-22
    Posted: 2014-08-15
    Designated public office holders:
    • Supriya Sharma, Acting Associate Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
  49. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2014-05-14
    Posted: 2014-06-16
    Designated public office holders:
    • David Belous, Manager, Stakeholder Relations & Outreach | Prime Minister's Office (PMO)
    Subject matters:
    • Health
  50. PURDUE PHARMA
    Type: In-house Corporation
    Occurred: 2014-04-14
    Posted: 2014-05-15
    Designated public office holders:
    • Jeremy Hunt, Director, Stakeholder Relations and Outreach | Prime Minister's Office (PMO)
    Subject matters:
    • Health

Date Modified: